Pfizer Wins Obesity Drug Battle
Digest more
For most of Big Pharma, drug discounts have largely been about damage control. After months of tariff threats and talk of ...
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...
The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.
Eli Lilly and Novo Nordisk agree to expand access and cut prices for Zepbound and Wegovy • Medicare to begin covering obesity ...
MedPage Today on MSN
Medicare to Cover Blockbuster Obesity Drugs
Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...
President Donald Trump announces discounted pricing for Zepbound and Wegovy and expanding Medicare coverage so more people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback